Literature DB >> 26040764

SOX 1, contrary to SOX 2, suppresses proliferation, migration, and invasion in human laryngeal squamous cell carcinoma by inhibiting the Wnt/β-catenin pathway.

Ning Yang1, Yan Wang2, Lian Hui2, Xiaotian Li2, Xuejun Jiang2.   

Abstract

Sex-determining region Y (SRY)-box protein 1 (SOX 1) has been reported to have the inhibiting effects on various cancer cells; however, the expression and effect of SOX 1 on laryngeal squamous cell carcinoma (LSCC) have not been determined. Therefore, the aim of this study was to assess the anti-proliferation and metastatic effects of SOX 1 and its related mechanisms on LSCC. According to our present study, first, we found that overexpression of SOX 1 could significantly inhibit proliferation and promote apoptosis in Tu212 cells. Additionally, overexpression of SOX 1 suppressed the migration and invasion potential of Tu212 cells via regulating Wnt/β-catenin pathway. Finally, we demonstrated for the first time that overexpression of SOX 1 could downregulate the expression of SOX 2, and co-expression of SOX 1 and SOX 2 could reverse the anti-tumor effect of SOX 1. In conclusion, our studies suggested that SOX 1 suppressed cell growth and invasion in Tu212 cells by inhibiting Wnt/β-catenin pathway, and the anti-tumor effect of SOX 1 could be weakened by SOX 2, which may be a potential molecular basis for clinical treatment of LSCC.

Entities:  

Keywords:  Apoptosis; LSCC; Metastasis; SOX 1; SOX 2; Wnt/β-catenin

Mesh:

Substances:

Year:  2015        PMID: 26040764     DOI: 10.1007/s13277-015-3389-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  39 in total

Review 1.  c-Myc target genes involved in cell growth, apoptosis, and metabolism.

Authors:  C V Dang
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

2.  The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors.

Authors:  H C Crawford; B M Fingleton; L A Rudolph-Owen; K J Goss; B Rubinfeld; P Polakis; L M Matrisian
Journal:  Oncogene       Date:  1999-05-06       Impact factor: 9.867

3.  Frequency of SOX Group B (SOX1, 2, 3) and ZIC2 antibodies in Turkish patients with small cell lung carcinoma and their correlation with clinical parameters.

Authors:  Burcak Vural; Lin-Chi Chen; Pinar Saip; Yao-Tseng Chen; Zeki Ustuner; Mithat Gonen; Andrew J G Simpson; Lloyd J Old; Ugur Ozbek; Ali O Gure
Journal:  Cancer       Date:  2005-06-15       Impact factor: 6.860

Review 4.  Profiling early head and neck cancer.

Authors:  Keith D Hunter; E Ken Parkinson; Paul R Harrison
Journal:  Nat Rev Cancer       Date:  2005-02       Impact factor: 60.716

5.  SOX9 expression and its methylation status in gastric cancer.

Authors:  Minhua Sun; Hiroshi Uozaki; Rumi Hino; Akiko Kunita; Aya Shinozaki; Tetsuo Ushiku; Takashi Hibiya; Kimiko Takeshita; Maya Isogai; Kenzo Takada; Masashi Fukayama
Journal:  Virchows Arch       Date:  2012-02-14       Impact factor: 4.064

6.  Estrogen receptor-α drives adiponectin effects on cyclin D1 expression in breast cancer cells.

Authors:  Loredana Mauro; Michele Pellegrino; Francesca Giordano; Emilia Ricchio; Pietro Rizza; Francesca De Amicis; Stefania Catalano; Daniela Bonofiglio; Maria Luisa Panno; Sebastiano Andò
Journal:  FASEB J       Date:  2015-02-05       Impact factor: 5.191

7.  Diagnostic variability of laryngeal premalignant lesions: histological evaluation and carcinoma transformation.

Authors:  Yanping Hu; Honggang Liu
Journal:  Otolaryngol Head Neck Surg       Date:  2013-12-23       Impact factor: 3.497

8.  An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

Authors:  Her-Young Su; Hung-Cheng Lai; Ya-Wen Lin; Yu-Ching Chou; Chin-Yu Liu; Mu-Hsien Yu
Journal:  Int J Cancer       Date:  2009-01-15       Impact factor: 7.396

9.  A gene mapping to the sex-determining region of the mouse Y chromosome is a member of a novel family of embryonically expressed genes.

Authors:  J Gubbay; J Collignon; P Koopman; B Capel; A Economou; A Münsterberg; N Vivian; P Goodfellow; R Lovell-Badge
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

10.  SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis.

Authors:  T Otsubo; Y Akiyama; K Yanagihara; Y Yuasa
Journal:  Br J Cancer       Date:  2008-02-12       Impact factor: 7.640

View more
  1 in total

1.  Oncogenic activity of SOX1 in glioblastoma.

Authors:  Idoia Garcia; Juncal Aldaregia; Jelena Marjanovic Vicentic; Paula Aldaz; Leire Moreno-Cugnon; Sergio Torres-Bayona; Estefania Carrasco-Garcia; Laura Garros-Regulez; Larraitz Egaña; Angel Rubio; Steven Pollard; Milena Stevanovic; Nicolas Sampron; Ander Matheu
Journal:  Sci Rep       Date:  2017-04-20       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.